Research interests
Neurosciences, Clinical Sciences, Medical Physiology, Cardiovascular Medicine and Haematology, Pharmacology and Pharmaceutical Sciences, Nutrition and Dietetics
Research overview:
Dr Bertrand is a gut health expert with a PhD in Pharmacology & Toxicology and over 70 publications on the workings of the gastrointestinal tract in health and disease. His research is based at RMIT University, Melbourne, and is affiliated with the Enabling Impact Platform (Biomedical and Health Innovation). He also has a conjoint appointment (https://med.unsw.edu.au/people/associate-professor-paul-bertrand) at the University of New South Wales, Sydney.
His research aims to improve the diagnoses of gastrointestinal disorders using state-of-the-art microsensor technology and to develop novel treatment strategies for gastrointestinal disorders His research focuses on the neuronal basis of functional bowel diseases and the neurophysiology of the peripheral nervous system in conditions such as obesity, inflammation and aging. He focuses on the roles of ATP and serotonin (5-HT) in neurotransmission and sensory transduction using electrophysiological and electrochemical techniques. The goal is to develop tailored diagnostics for a variety of gastrointestinal disorders such as Inflammatory Bowel Disease, Irritable Bowel Syndrome and conditions such as type 2 diabetes.
He is an Associate Editor for Frontiers in Neuroscience and on the Editorial Board for Clinical and Experimental Pharmacology and Physiology, and Neurogastroenterology and Motility. He is also a member of several international and Australian societies and is on the executive of the Australasian Neurogastroenterology and Motility Association, and the International Society for Serotonin Research.
Dr Bertrand was recently highlighted in the annual RMIT alumni magazine,(https://alumnimagazine.rmit.edu.au/the-global-issue/the-worlds-within/?_gl=1*18vo7c*_gcl_au*MTk0OTI5MTE5OC4xNzEzMDkzMzI4) is a top contributor to the news website (https://theconversation.com/profiles/paul-bertrand-7622) and is regularly invited to comment on gastrointestinal health issues in the media in print (Nature, 533, S116–S117) and on national radio (Tony Delroy's Nightlife 16/5/16).